高齢者の栄養の世界市場

高齢者の栄養の世界市場は2030年までに337億米ドルに達する見込み

2024年に245億米ドルと推定される高齢者の栄養の世界市場は、2024年から2030年にかけてCAGR 5.4%で成長し、2030年には337億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるタンパク質は、CAGR 5.8%を記録し、分析期間終了時には81億米ドルに達すると予想されます。ミネラル分野の成長率は、分析期間中CAGR 6.6％と推定されます。

米国市場は67億米ドルと推定、中国はCAGR 8.6％で成長予測

米国の高齢者の栄養市場は、2024年には67億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに68億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と5.4%と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

世界の高齢者の栄養市場- 主要動向と促進要因のまとめ

なぜ高齢者の栄養は世界のヘルスケアにおける優先事項となりつつあるのか？

高齢者の栄養は、高齢者人口が世界中で拡大し、高齢者の健康的な加齢、疾病予防、QOLをサポートする食事戦略に対する緊急のニーズが高まる中、ヘルスケアの重要な焦点として浮上しています。平均寿命が延び、60歳以上の高齢者は世界で最も急成長している人口集団の一つとなっています。しかし、加齢に伴い、食欲の減退、代謝の低下、栄養吸収の低下、味覚や嗅覚の喪失など、栄養ニーズや食習慣に影響を及ぼす生理的変化が生じることが多いです。骨粗しょう症、糖尿病、心血管疾患、認知機能低下などの慢性疾患は、このライフステージでより一般的になるため、症状を管理し転帰を改善するための的確な栄養介入が必要となります。栄養不良や筋肉の衰え（サルコペニア）も高齢者によく見られ、虚弱、入院、ヘルスケアコストの増加につながります。その結果、良質のタンパク質、ビタミン（特にD、B12、葉酸）、食物繊維、カルシウム、オメガ3脂肪酸を豊富に含むバランスのとれた栄養摂取が不可欠となります。高齢者の栄養製品は、栄養強化飲料や栄養補助食品から、食感改良食品や特殊な代替食品に至るまで、食生活のギャップを埋める上で極めて重要な役割を果たしています。高齢化が公衆衛生政策の中心となっている現在、高齢者に最適な栄養を確保することはもはやオプションではなく、健康長寿、自立した生活、ヘルスケアの持続可能性向上のための基礎となる柱です。

製品イノベーションとパーソナライゼーションは、高齢者の栄養ソリューションをどのように変革しているか？

技術と栄養学の進歩は高齢者の栄養市場を再形成し、よりパーソナライズされた、便利で科学的に調整された製品へと導いています。食品会社や栄養補助食品会社は、臨床研究やデータ分析を活用して、年齢、性別、病歴、ライフスタイルに基づく高齢者特有のニーズに対応する栄養ソリューションを開発しています。革新的なものとしては、サルコペニアと闘うために設計されたタンパク質強化飲料、脳の健康をサポートするためのオメガ 3と抗酸化物質強化サプリメント、消化機能を強化するためのプレバイオティクス強化製剤などがあります。AIを活用した健康評価やDNAベースのプロファイリングを利用して、高齢者向けにカスタマイズされた食事やサプリメントを推奨するパーソナライズド栄養プラットフォームが出現しています。嚥下障害（飲み込みが困難な状態）患者向けの食感改良食品は、安全基準を満たしながら風味と体裁を維持するように作られたピューレ状またはソフト食品によって、より洗練されたものになりつつあります。機能性スナック、栄養強化乳製品、調理済み食品も、食事の準備に煩わされることなく栄養を摂取したい高齢消費者向けに開発されています。さらに、イージーオープン容器、分量管理、明確なラベル表示といったパッケージの革新により、身体的または認知的に制限のある高齢者のアクセシビリティとユーザビリティが向上しています。こうしたパーソナライゼーションへのシフトは、臨床転帰や栄養計画の遵守を高めるだけでなく、消費者の体験を向上させる。

なぜ地域の人口動態とヘルスケアシステムが高齢者の栄養の動向に影響を与えるのか？

高齢者の栄養の動向は、地域の人口統計、文化的な食の嗜好、ヘルスケア提供モデルによって大きく左右されるため、世界の地域によって市場成長や製品開拓にかなりの差が生じています。日本、ドイツ、米国などの高所得国では、人口の高齢化がすでに主要な社会的要因となっており、高齢者向け栄養製品やサービスに対する強い需要が促されています。これらの市場は、先進的なヘルスケア・システム、政府支援による高齢化対策、食事介入に関する消費者の意識の高さといった特徴を有しており、これらが総体的に高齢者の栄養におけるイノベーションとアクセシビリティを後押ししています。世界最高齢の人口を抱える日本は、地域ベースの栄養プログラムおよび特定の加齢関連状態に合わせた医療用食品のパイオニアです。欧州では、高齢者介護施設や在宅介護サービスが、保険適用や公衆衛生政策に支えられながら、個別化された栄養計画を治療レジメンに組み入れる傾向を強めています。一方、インド、ブラジル、東南アジアの一部などの新興国では、高齢化人口が急速に増加しているが、ヘルスケアのインフラや栄養リテラシーが遅れていることが多いです。伝統的な食生活、経済的な制約、強化食品へのアクセス制限などが、高齢者の栄養の取り組みの妨げとなっています。しかし、中流階級の所得向上と都市化により、手頃な価格で地元に適合した高齢者の栄養製品の市場は徐々に拡大しています。このような地域格差は、高齢者の栄養の世界的公平性を確保するために、的を絞った政策開発、文化に配慮した製品設計、官民パートナーシップの必要性を浮き彫りにしています。

世界の高齢者の栄養市場の成長を促進する主な要因は？

世界の高齢者の栄養市場の成長は、高齢化社会における栄養の役割を強調する人口統計学的、医療的、経済的、技術的な要因によって促進されています。国連によると、2050年までに15億人を超えると予測されています。この人口動態の変化と並行して、骨密度の低下、認知機能の低下、心血管疾患など、的を絞った食事戦略によって管理または軽減できる加齢に関連した健康状態の有病率が上昇しています。ヘルスケアプロバイダーおよび政策立案者は、栄養を予防的ヘルスケアツールとして認識するようになっており、食事評価および介入を高齢者ケアのプロトコルに含めることを促しています。同時に、退職者の可処分所得の増加、健康意識の高まり、ウェルネス情報のデジタル化により、高齢消費者は栄養面での解決策をより積極的に求めるようになっています。eコマースや遠隔医療プラットフォームの拡大も、高齢者や介護者が個別のサプリメントや食事計画にアクセスすることを容易にしています。さらに、業界各社は臨床試験や規制当局の承認に裏打ちされた医療用栄養製品を開発するため、研究開発に投資しています。世界のヘルスケア・システムが疾病治療から予防とウェルネスへとシフトする中、高齢者の栄養は食品、健康、高齢化の交差点に位置し、高齢者の健康でより長く充実した生活をサポートする市場の拡大とイノベーションを強力に推進しています。

セグメント

栄養タイプ（タンパク質、ミネラル、マルチビタミン、繊維、脂質、抗酸化物質、鉄分）、アプリケーション（肥満、糖尿病、腎不全、がん、サルコペニア、認知機能低下、身体虚弱、その他のアプリケーション）、流通チャネル（病院薬局、小売薬局、オンライン薬局）

調査対象企業の例（全48件）

• AAK AB
• Abbott Laboratories
• Ajinomoto Co., Inc.
• Baxter International Inc.
• Bayer AG
• Danone S.A.
• DSM-Firmenich AG
• Fonterra Co-operative Group
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Meiji Holdings Co., Ltd.
• Nestle Health Science
• Novartis AG
• Nutreat Australia
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Sanofi S.A.
• Synlait Ltd.
• The Vitamin Company India
• Unilever plc

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Elderly Nutrition Market to Reach US$33.7 Billion by 2030

The global market for Elderly Nutrition estimated at US$24.5 Billion in the year 2024, is expected to reach US$33.7 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Protein, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$8.1 Billion by the end of the analysis period. Growth in the Minerals segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.7 Billion While China is Forecast to Grow at 8.6% CAGR

The Elderly Nutrition market in the U.S. is estimated at US$6.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Elderly Nutrition Market - Key Trends & Drivers Summarized

Why Is Elderly Nutrition Becoming a Global Healthcare Priority?

Elderly nutrition is emerging as a critical healthcare focus as aging populations expand across the globe, driving an urgent need for dietary strategies that support healthy aging, disease prevention, and quality of life in older adults. With life expectancy increasing, individuals over 60 now represent one of the fastest-growing demographic groups worldwide. However, aging often brings physiological changes that affect nutritional needs and dietary habits-such as reduced appetite, slower metabolism, impaired nutrient absorption, and the loss of taste or smell. Chronic diseases including osteoporosis, diabetes, cardiovascular issues, and cognitive decline become more prevalent in this life stage, requiring precise nutritional interventions to manage symptoms and improve outcomes. Malnutrition and muscle wasting (sarcopenia) are also common among the elderly, leading to increased frailty, hospitalizations, and healthcare costs. As a result, balanced nutrition rich in high-quality protein, vitamins (especially D, B12, and folate), fiber, calcium, and omega-3 fatty acids becomes essential. Elderly nutrition products-from fortified drinks and protein supplements to texture-modified foods and specialized meal replacements-play a pivotal role in bridging dietary gaps. With aging now at the center of public health policy, ensuring optimal nutrition for older adults is no longer optional-it’s a foundational pillar for healthy longevity, independent living, and improved healthcare sustainability.

How Are Product Innovation and Personalization Transforming Elderly Nutrition Solutions?

Technological and nutritional advancements are reshaping the elderly nutrition market, leading to more personalized, convenient, and scientifically tailored products. Food companies and nutraceutical firms are leveraging clinical research and data analytics to develop nutrition solutions that address the specific needs of older adults based on age, gender, medical history, and lifestyle. Innovations include protein-enriched beverages designed to combat sarcopenia, omega-3 and antioxidant-enriched supplements to support brain health, and prebiotic-fortified formulas to enhance digestive function. Personalized nutrition platforms are emerging that use AI-driven health assessments or DNA-based profiling to recommend customized diets and supplements for seniors. Texture-modified foods for individuals with dysphagia (swallowing difficulties) are becoming more sophisticated, with pureed or soft foods crafted to preserve flavor and presentation while meeting safety standards. Functional snacks, fortified dairy, and ready-to-eat meals are also being developed for elderly consumers seeking nutrition without the complexity of meal prep. Additionally, packaging innovations like easy-open containers, portion-controlled servings, and clear labeling are improving accessibility and usability for seniors with physical or cognitive limitations. This shift toward personalization not only enhances clinical outcomes and adherence to nutritional regimens but also elevates the consumer experience-empowering seniors to enjoy food again as both nourishment and pleasure, tailored to their unique aging journey.

Why Do Regional Demographics and Healthcare Systems Influence Elderly Nutrition Trends?

Elderly nutrition trends are shaped heavily by regional demographics, cultural food preferences, and healthcare delivery models, leading to considerable variation in market growth and product development across global regions. In high-income countries such as Japan, Germany, and the U.S., aging populations are already a dominant social factor, prompting strong demand for geriatric nutrition products and services. These markets are characterized by advanced healthcare systems, government-supported aging initiatives, and higher consumer awareness about dietary interventions, which collectively drive innovation and accessibility in elderly nutrition. Japan, with the world’s oldest population, has pioneered community-based nutritional programs and medical foods tailored to specific age-related conditions. In Europe, elderly care facilities and home care services increasingly integrate personalized nutrition plans into treatment regimens, supported by insurance coverage and public health policies. Meanwhile, in emerging economies like India, Brazil, and parts of Southeast Asia, aging populations are growing rapidly, but healthcare infrastructure and nutrition literacy often lag behind. Traditional diets, affordability constraints, and limited access to fortified foods can hinder elderly nutrition efforts. However, rising middle-class income and urbanization are slowly expanding the market for affordable, locally adapted elderly nutrition products. These regional disparities highlight the need for targeted policy development, culturally sensitive product design, and public-private partnerships to ensure global equity in elderly nutrition.

What Are the Key Drivers Fueling Growth in the Global Elderly Nutrition Market?

The growth in the global elderly nutrition market is fueled by a convergence of demographic, medical, economic, and technological forces that collectively emphasize the role of nutrition in aging well. The single most influential driver is the rapid increase in the elderly population, particularly those aged 65 and older, projected to surpass 1.5 billion by 2050 according to the United Nations. This demographic shift is paralleled by the rising prevalence of age-related health conditions that can be managed or mitigated through targeted dietary strategies-such as bone density loss, cognitive decline, and cardiovascular disease. Healthcare providers and policymakers are increasingly recognizing nutrition as a preventive healthcare tool, prompting the inclusion of dietary assessments and interventions in geriatric care protocols. Concurrently, higher disposable income among retirees, greater health awareness, and the digitalization of wellness information are making elderly consumers more proactive in seeking nutritional solutions. The expansion of e-commerce and telehealth platforms is also making it easier for seniors and caregivers to access personalized supplements and meal plans. Moreover, industry players are investing in R&D to develop medical nutrition products backed by clinical trials and regulatory approvals. As global healthcare systems shift from disease treatment to prevention and wellness, elderly nutrition is positioned at the intersection of food, health, and aging-driving robust market expansion and innovation that supports healthier, longer, and more fulfilling lives for older adults.

SCOPE OF STUDY:

The report analyzes the Elderly Nutrition market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Nutrition Type (Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants, Iron); Application (Obesity, Diabetes, Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• AAK AB
• Abbott Laboratories
• Ajinomoto Co., Inc.
• Baxter International Inc.
• Bayer AG
• Danone S.A.
• DSM-Firmenich AG
• Fonterra Co-operative Group
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Meiji Holdings Co., Ltd.
• Nestle Health Science
• Novartis AG
• Nutreat Australia
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Sanofi S.A.
• Synlait Ltd.
• The Vitamin Company India
• Unilever plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Elderly Nutrition - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Aging Demographics Throw the Spotlight on Elderly Nutrition as a Healthcare Priority
  • Rising Prevalence of Sarcopenia and Muscle Loss Propels Demand for High-Protein Senior Formulas
  • Here's How Functional and Medical Nutrition Trends Drive Formulation of Age-Targeted Products
  • Shift Toward Personalized Nutrition Strengthens Business Case for Cognitive and Joint Health Solutions
  • Increased Focus on Immune Health in Aging Populations Accelerates Development of Micronutrient-Rich Blends
  • Oral Health Challenges and Dysphagia Risks Spur Innovation in Easy-to-Swallow and Texture-Modified Foods
  • Here's the Story: Home-Based Care and Telehealth Growth Drive Demand for Convenient Nutritional Formats
  • Public Health Campaigns and Aging-In-Place Models Expand Access to Senior-Focused Dietary Products
  • Growth in Protein-Fortified Dairy and Plant-Based Alternatives Enhances Market Diversity
  • Cognitive Decline Prevention Strategies Generate Interest in Omega-3, Choline, and MCT-Based Nutrition
  • Premiumization in Elderly Wellness Encourages Use of Functional Superfoods and Botanical Additives
  • Increased Longevity Awareness Supports Preventive Nutrition Over Therapeutic-Only Formulations
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Elderly Nutrition Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Elderly Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Elderly Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Elderly Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Protein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Multi-Vitamins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Multi-Vitamins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Multi-Vitamins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Fibers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Fibers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Fibers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Lipids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Lipids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Lipids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Antioxidants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Antioxidants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Antioxidants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Iron by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Iron by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Iron by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Renal Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Renal Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Renal Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Sarcopenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Sarcopenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Sarcopenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cognitive Decline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cognitive Decline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Cognitive Decline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Physical Frailty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Physical Frailty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Physical Frailty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 59: USA Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• JAPAN
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• CHINA
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• EUROPE
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Elderly Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Elderly Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• FRANCE
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• GERMANY
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 143: Spain Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Spain Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Spain 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 152: Russia Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Russia Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Russia 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 155: Russia Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Russia Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Russia 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Europe Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Rest of Europe 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Rest of Europe Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Rest of Europe 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Rest of Europe Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Rest of Europe 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for Elderly Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for Elderly Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Asia-Pacific Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Asia-Pacific 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Asia-Pacific Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Asia-Pacific 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Asia-Pacific Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Asia-Pacific 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 182: Australia Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Australia Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Australia 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 185: Australia Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Australia Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Australia 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 188: Australia Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Australia Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Australia 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• INDIA
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 191: India Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: India Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: India 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 194: India Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: India Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: India 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 197: India Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: India Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: India 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 200: South Korea Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: South Korea Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: South Korea 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 203: South Korea Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: South Korea Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: South Korea 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 206: South Korea Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: South Korea Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: South Korea 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 209: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Asia-Pacific Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Rest of Asia-Pacific 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Asia-Pacific Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Rest of Asia-Pacific 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Rest of Asia-Pacific Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Rest of Asia-Pacific 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for Elderly Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for Elderly Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 221: Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Latin America Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Latin America 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 224: Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Latin America Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Latin America 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 227: Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Latin America Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Latin America 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 230: Argentina Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Argentina Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Argentina 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 233: Argentina Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Argentina Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Argentina 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 236: Argentina Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Argentina Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Argentina 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 239: Brazil Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Brazil Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Brazil 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 242: Brazil Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Brazil Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Brazil 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 245: Brazil Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Brazil Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Brazil 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 248: Mexico Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Mexico Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Mexico 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 251: Mexico Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Mexico Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Mexico 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 254: Mexico Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Mexico Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Mexico 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 257: Rest of Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Latin America Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Latin America 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 260: Rest of Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Latin America Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Latin America 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Latin America Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Latin America 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for Elderly Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for Elderly Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 269: Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Middle East Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Middle East 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 272: Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Middle East Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Middle East 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 275: Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Middle East Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Middle East 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 278: Iran Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Iran Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Iran 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 281: Iran Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Iran Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Iran 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 284: Iran Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Iran Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Iran 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 287: Israel Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Israel Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Israel 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 290: Israel Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Israel Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Israel 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 293: Israel Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Israel Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Israel 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 296: Saudi Arabia Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Saudi Arabia Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Saudi Arabia 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 299: Saudi Arabia Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Saudi Arabia Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Saudi Arabia 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 302: Saudi Arabia Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Saudi Arabia Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Saudi Arabia 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 305: UAE Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: UAE Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: UAE 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 308: UAE Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: UAE Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: UAE 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 311: UAE Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: UAE Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: UAE 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 314: Rest of Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Middle East Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Middle East 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Middle East Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Middle East 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Middle East Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Middle East Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Middle East 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030
• AFRICA
  • Elderly Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 323: Africa Recent Past, Current & Future Analysis for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Africa Historic Review for Elderly Nutrition by Nutrition Type - Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Africa 15-Year Perspective for Elderly Nutrition by Nutrition Type - Percentage Breakdown of Value Sales for Protein, Minerals, Multi-Vitamins, Fibers, Lipids, Antioxidants and Iron for the Years 2015, 2025 & 2030
  • TABLE 326: Africa Recent Past, Current & Future Analysis for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Africa Historic Review for Elderly Nutrition by Application - Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Africa 15-Year Perspective for Elderly Nutrition by Application - Percentage Breakdown of Value Sales for Renal Failure, Cancer, Sarcopenia, Cognitive Decline, Physical Frailty, Other Applications, Obesity and Diabetes for the Years 2015, 2025 & 2030
  • TABLE 329: Africa Recent Past, Current & Future Analysis for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Africa Historic Review for Elderly Nutrition by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Africa 15-Year Perspective for Elderly Nutrition by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2015, 2025 & 2030

IV. COMPETITION